← Back to Search

Procedure

Distal transradial access (dTRA) for Coronary Angiography

N/A
Waitlist Available
Research Sponsored by Inova Health Care Services
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days post-cardiac catheterization
Awards & highlights

Study Summary

Distal Transradial Access for Percutaneous Coronary Intervention

Eligible Conditions
  • Transradial Access
  • Coronary Angiography
  • Radial Artery Intimal Medial Thickness
  • Distal Radial Artery Access

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days post-cardiac catheterization
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days post-cardiac catheterization for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Radial artery intimal medial thickness following dTRA and fTRA
Secondary outcome measures
Access site crossover
Coronary dissection
Duration of hemostasis
+8 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Distal transradial access (dTRA)Experimental Treatment1 Intervention
Subjects randomized to the experimental arm will undergo left heart catheterization using distal transradial access (dTRA) to facilitate coronary angiography and/or percutaneous coronary intervention.
Group II: Forearm radial access (fTRA)Active Control1 Intervention
Cardiac catheterization to facilitate coronary angiography and/or percutaneous coronary intervention using the standard forearm radial artery which is the current standard of care in interventional cardiology.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
dTRA
2021
N/A
~70

Find a Location

Who is running the clinical trial?

Inova Health Care ServicesLead Sponsor
69 Previous Clinical Trials
22,195 Total Patients Enrolled
Boston Scientific CorporationIndustry Sponsor
718 Previous Clinical Trials
932,884 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
~18 spots leftby Apr 2025